← Back to headlines
Wolfe Research Bullish on Eli Lilly's Obesity Pipeline
Wolfe Research maintains a bullish outlook on Eli Lilly and Company, citing strong prospects for its pipeline of obesity drugs and potential market growth.
28 May, 11:37 — 28 May, 11:37
Sources
Showing 1 of 1 sources
Related Stories
South Korean Retail Investors Shift Billions to US Stocks Amid ETF Curbs
58m ago
HDFC Bank CEO Sashidhar Jagdishan to Step Down in October
3h ago
FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder
4h ago
UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings
5h ago